Abstract
Dendritic cells (DCs) are the most efficient antigen-presenting cells and play a key role in a cellular antitumor immune response. In this study we investigated the exact localization of DCs within colorectal tumors and their relationship to tumor-infiltrating lymphocytes as well as clinical outcome of the patients. Primary tumor specimens of 104 patients with a diagnosis of colorectal cancer were identified retrospectively and analyzed with the dendritic cell markers S-100 protein and human leukocyte antigens (HLA) class II. The markers were individually combined with laminin as a second marker to facilitate the observation of the different tumor localizations. S-100 or HLA class II positive cells were found in the three different compartments of colorectal tumors: tumor epithelium, tumor stroma, and advancing tumor margin, but mainly present in tumor stroma and advancing tumor margin. S-100–positive tumor-infiltrating DCs in direct contact with tumor cells, i.e., in tumor epithelium, significantly correlated to the intraepithelial infiltration of CD4+ (p=0.02) and CD8+ (p=0.01) lymphocytes. High HLA class II+ cell infiltration in the tumor stroma correlated to a lower intraepithelial infiltration of CD8+ (p=0.02) lymphocytes. High intraepithelial infiltration of S-100–positive DCs suggested increased disease-free survival, but was not statistically significant, while high amounts of HLA class II+ cells in the tumor stroma correlated with an adverse survival outcome. Our results show that the infiltration of DCs in colorectal cancer, depending on both location and type of marker, is correlated with local immune interactions and patient prognosis, suggesting a central role for DCs in controlling local tumor immunity.
Similar content being viewed by others
Abbreviations
- CTL:
-
Cytotoxic T lymphocyte
- DC:
-
Dendritic cell
- HPF:
-
High-power field
- HLA:
-
Human leukocyte antigen
- MHC:
-
Major histocompatibility complex
- NS:
-
Not significant
- TIL:
-
Tumor-infiltrating leukocyte
References
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Bell D, Young JW, Banchereau J (1999) Dendritic cells. Adv Immunol 72:255–324
Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296
Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621–667
Alavaikko MJ, Blanco G, Aine R, Lehtinen T, Fellbaum C, Taskinen PJ, Sarpola A, Hansmann ML (1994) Follicular dendritic cells have prognostic relevance in Hodgkin’s disease. Am J Clin Pathol 101:761–767
Ambe K, M Mori, Enjoji M (1989) S-100 protein-positive dendritic cells in colorectal adenocarcinomas: distribution and relation to the clinical prognosis. Cancer 63:496–503
Bethwaite PB, Holloway LJ, Thornton A, Delahunt B (1996) Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 28:321–327
Furihata M, Ohtsuki Y, Ido E, Iwata J, Sonobe H, Araki K, Ogoshi S, Ohmori K (1992) HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma—their distribution in relation to prognosis. Virchows Arch B Cell Pathol Incl Mol Pathol 61:409–414
Giannini A, Bianchi S, Messerini L, Gallo O, Gallina E, Asprella LG, Olmi P, Zampi G (1991) Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma. Pathol Res Pract 187:496–502
Inoue K, Furihata M, Ohtsuki Y, Fujita Y (1993) Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch A Pathol Anat Histopathol 422:351–355
Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Xiangming C, Iwashige H, Aridome K, Hokita S, Aikou T (2000) Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett 159:103–108
Mori M, Ambe K, Adachi Y, Yakeishi Y, Nakamura K, Hachitanda Y, Enjoji M, Sugimachi K (1988) Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 protein-positive cells in gastric carcinoma. Cancer 62:534–540
Papla B, Dubiel-Bigaj M, Stachura J (1988) Dendritic cells in bronchial adenocarcinoma. Folia Histochem Cytobiol 26:99–103
Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL (2001) The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91:2136–2147
Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W (1988) Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol 89:295–300
Zeid NA, Muller HK (1993) S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 25:338–343
Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491–3494
Suzuki A, Masuda A, Nagata H, Kameoka S, Kikawada Y, Yamakawa M, Kasajima T (2002) Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 196:37–43
Menon AG, Fleuren GJ, Alphenaar EA, Jonges LE, Janssen Van Rhijn CM, Ensink NG, Putter H, Tollenaar RA, van de Velde CJ, Kuppen PJ (2003) A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer. Cancer Immunol Immunother 52:121–126
Schwaab T, Weiss JE, Schned AR, Barth RJ Jr (2001) Dendritic cell infiltration in colon cancer. J Immunother 24:130–137
Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, Radojkovic M, Restall AP, Stables SR, Zwi LJ (1996) Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 28:543–548
LaSalle JM, Ota K, Hafler DA (1991) Presentation of autoantigen by human T cells. J Immunol 147:774–780
Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Nagashima N, Onitsuka K, Tsurudome Y, Sako T, Hirata K, Nagata N, Itoh H (2003) Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. Anticancer Res 23:4423–4426
Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, Hermans J, van Dierendonck JH (1998) Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer 77:1842–1847
Acknowledgements
This work was supported by Grant 2000-2135 from the Dutch Cancer Society (KWF).
Author information
Authors and Affiliations
Corresponding author
Additional information
A.R. Dadabayev and M.H. Sandel contributed equally to this manuscript
Rights and permissions
About this article
Cite this article
Dadabayev, A.R., Sandel, M.H., Menon, A.G. et al. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother 53, 978–986 (2004). https://doi.org/10.1007/s00262-004-0548-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-004-0548-2